Drawing for IMMUNOVANT

USPTO serial 88514206

IMMUNOVANT

Reviewed by CopyMark Law Group

Reg. 6127711Status 702Renewal
Filing date
Status date
Registration date
Aug 18, 2020
Examiner
LIEBL, ALEXANDRA
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with IMMUNOVANT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Douglas R. Wolf

Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human use for the treatment of immune system related diseases, disorders and conditions; pharmaceutical preparations for human use for the treatment of autoimmune diseases, disorders and conditions; biological preparations for medical and therapeutic use for the treatment of immune system related diseases, disorders and conditions; biological preparations for medical and therapeutic use for the treatment of autoimmune diseases, disorders and conditions; pharmaceutical and biological preparations for medical and therapeutic use for treating immune system related diseases, disorders and conditions; pharmaceutical and biological preparations for medical and therapeutic use for treating autoimmune diseases, disorders and conditionsACTIVE—
042Scientific and technological services, namely, medical research, scientific research and analysis, and diagnostic services in the fields of immunology and autoimmunity; biomedical and pharmaceutical research services; scientific research in the field of therapeutic biological and pharmaceutical preparations; pharmaceutical research and development; providing scientific research information relating to scientific research in the field of pharmaceuticals and biomedicineACTIVE—
044Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 6, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 6, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 3, 2026EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Sep 1, 2026PR23POST REGISTRATION ACTION MAILED - SEC. 8 & 15—
Aug 31, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 31, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 2, 2026E815TEAS SECTION 8 & 15 RECEIVED—
May 13, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 18, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 19, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 19, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 19, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 19, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 19, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 19, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 18, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 2, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 2, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 27, 2020FIXDELECTRONIC RECORD REVIEW COMPLETE—
Apr 24, 2020ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Apr 9, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 3, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 3, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 3, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 24, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2019DOCKASSIGNED TO EXAMINER—
Oct 1, 2019DOCKASSIGNED TO EXAMINER—
Jul 20, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 19, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 18, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance